peripheral mononuclear blood cells
Recently Published Documents


TOTAL DOCUMENTS

46
(FIVE YEARS 0)

H-INDEX

12
(FIVE YEARS 0)

2019 ◽  
Vol 14 (2) ◽  
pp. 025004 ◽  
Author(s):  
Alena-Svenja Wagner ◽  
Matthias Schumacher ◽  
Marcus Rohnke ◽  
Kristina Glenske ◽  
Michael Gelinsky ◽  
...  

2018 ◽  
Vol 25 (2) ◽  
pp. 329-333 ◽  
Author(s):  
Paweł Półrola ◽  
Magdalena Wilk-Franczuk ◽  
Jacek Wilczyński ◽  
Grażyna Nowak – Starz ◽  
Jolanta Góral-Półrola ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Kenneth Thirstrup ◽  
Justus C. Dächsel ◽  
Felix S. Oppermann ◽  
Douglas S. Williamson ◽  
Garrick P. Smith ◽  
...  

2017 ◽  
Vol 45 (1) ◽  
pp. 31-39 ◽  
Author(s):  
Timur Saliev ◽  
Dinara Begimbetova ◽  
Dinara Baiskhanova ◽  
Danysh Abetov ◽  
Ulykbek Kairov ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Jin-Biao Liu ◽  
Li Zhou ◽  
Yi-Zhong Wang ◽  
Xu Wang ◽  
Yu Zhou ◽  
...  

Lipopolysaccharide- (LPS-) mediated systemic inflammation plays a critical role in neurodegenerative diseases. The present study was conducted to evaluate the protective effects of epigallocatechin gallate (EGCG), the major component in green tea, on LPS-mediated inflammation and neurotoxicity. LPS treatment of macrophages induced expression of proinflammatory cytokines (TNF-α, IL-1β, and IL-6). However, EGCG pretreatment of macrophages significantly inhibited LPS-mediated induction of these cytokines. In addition, EGCG significantly diminished LPS-induced inflammatory cytokines in the peripheral mononuclear blood cells (PBMCs). Supernatant from EGCG-pretreated and LPS-activated macrophage cultures was found to be less cytotoxic to neurons than that from non-EGCG-pretreated and LPS-activated macrophage cultures. Furthermore, EGCG treatment of neurons could inhibit LPS-induced production of reactive oxygen species (ROS). Thus EGCG represents a potent and useful neuroprotective agent for inflammation-mediated neurological disorders.


Sign in / Sign up

Export Citation Format

Share Document